Nicole Hersmus

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Early and Divergent Lipid Mediator Remodelling in Fast Versus Slow Skeletal Muscles of Female hSOD1G93A Mice.

Early and Divergent Lipid Mediator Remodelling in Fast Versus Slow Skeletal Muscles of Female hSOD1G93A Mice.

Journal: Journal of cachexia, sarcopenia and muscle

Published: March 16, 2026

Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS.

Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS.

Journal: Journal of neurology

Published: March 16, 2024

Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis.

Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: November 07, 2022

C9orf72 hexanucleotide repeat expansions impair microglial response in ALS.

C9orf72 hexanucleotide repeat expansions impair microglial response in ALS.

Journal: Nature neuroscience

Published: October 13, 2022

HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS.

HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS.

Journal: Acta neuropathologica

Published: May 06, 2022

CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.

CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 04, 2022

Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes.

Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes.

Journal: Cellular and molecular life sciences : CMLS

Published: November 05, 2021

HDAC3 Inhibition Stimulates Myelination in a CMT1A Mouse Model.

HDAC3 Inhibition Stimulates Myelination in a CMT1A Mouse Model.

Journal: Molecular neurobiology

Published: August 27, 2021

AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS.

AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS.

Journal: Molecular therapy. Methods & clinical development

Published: August 18, 2020

Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity.

Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity.

Journal: Cell reports

Published: September 13, 2017

A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism.

A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism.

Journal: Acta neuropathologica

Published: July 31, 2017

Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis.

Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: February 05, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026